Shah Syed Raza, Fatima Kaneez, Ansari Mehreen
Dow University of Health Sciences (DUHS), Karachi, Pakistan,
J Interv Card Electrophysiol. 2014 Dec;41(3):193-4. doi: 10.1007/s10840-014-9939-2. Epub 2014 Sep 26.
The burden of noncommunicable diseases (NCDs) is emerging as a major public health challenge for the world. NCDs are projected to account for around 75 % of global mortality by the year 2020. The most common and problematic of all noncommunicable conditions is heart disease. As such, the weight of evidence supporting the routine use of cardiac resynchronization therapy (CRT) as a fruitful treatment for patients with ventricular dyssynchrony and moderate to severe chronic systolic heart failure is now quite substantial. The recent study done by Kirk et al. adds to our understanding of the effects of CRT in treating heart failure patients. Whether the current observations and findings extend to the more common clinical situations remains to be determined.
非传染性疾病（NCDs）正成为全球主要的公共卫生挑战。预计到2020年，非传染性疾病将占全球死亡人数的75%左右。所有非传染性疾病中最常见且问题最大的是心脏病。因此，支持将心脏再同步治疗（CRT）作为治疗心室不同步和中度至重度慢性收缩性心力衰竭患者的有效治疗方法的证据现在相当充分。柯克等人最近进行的研究增进了我们对CRT治疗心力衰竭患者效果的理解。目前的观察结果和发现是否适用于更常见的临床情况仍有待确定。
